Drugs / 18F-choline
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02640313 | Dec 2015 → Mar 2024 | atherosclerosis | Maastricht University Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT03555487 | May 2015 → Jun 2018 | parathyroid gland disorder | National Taiwan University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F choline | “11C or 18F choline is a PET probe used in imaging prostate cancer and hepatocellular carcinoma.” NCT03555487 ↗ |
| Modality | Diagnostic / imaging agent | “radiolabeled-choline (18F-choline) is a sensitive molecular tracer for PET imaging” NCT02640313 ↗ |
| Route | Intravenous | “administered intravenously as a single dose.” NCT02640313 ↗ |